A prospective study of branch duct intraductal papillary mucinous neoplasm of the pancrease; a single-center prospective study.

A prospective study of branch duct intraductal papillary mucinous neoplasm of the pancrease; a single-center prospective study. - A prospective surveillance study of brunch duct IPMN.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009286

Enrollment

400

Registered

2012-11-09

Start date

2012-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Branch duct intraductal mucinous papillary neoplasm of the pancrease(BD-IPMN).

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients diagnosed as BD-IPMN, which has a communication with MPD detected by MRCP or EUS or ERCP. 2) Patients having fish-eye appearance of duodenal papilla or apparent mucin in pancreatic duct found in ERCP. 3) Patients over 20 years 4) Patients accepted informed consent

Exclusion criteria

Exclusion criteria: 1) MPD diameter more than 10mm 2) mural nodule more than 5mm 3) pancreatic stones and dilated or stenotic MPD induced by chronic pancreatitis 4) concomitant with pancreatic ductal adenocarcinoma at the diagnosis 5) considered ineligible by attendant doctors

Design outcomes

Primary

Measure	Time frame
The progression of BD-IPMN	—

Secondary

Measure	Time frame
The incidence of carcinoma derived from BD-IPMN and ductal carcinoma concomitant with BD-IPM.	—

Countries

Japan

Contacts

Public ContactTomohisa Iwai

Kitasato University School of Medicine Gastroenterology

t-iwai@kitasato-u.ac.jp042-778-8111

Outcome results